Empress Therapeutics
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $40M
Investors
- 1
About Empress Therapeutics
Founded in 2020 and based in Massachusetts, US, Empress Therapeutics, Inc. operates as a drug development company that offers small-molecule drugs. The company was founded by its CEO, Jason Park, Noubar Afeya, Sabrina Yang, John Mendlein, and Doug Cole. In June 2023, Empress Therapeutics, Inc. Empress Therapeutics offers a Chemilogics platform, a biotech platform that uses patient data, DNA, artificial intelligence, small molecule chemistry, and synthetic biology to discover small molecule drugs in the human body. The company collects metagenomic data from patients to identify genes that encode for small-molecule compounds, uses machine learning to predict their potential drug properties, and develops oral medicines for a variety of diseases.
Who invested in Empress Therapeutics
1 investor across 1 round
See all investors in Empress Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 21, 2023
Amount
$40M
Investors
Questions about Empress Therapeutics
Who invested in Empress Therapeutics?
Empress Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Empress Therapeutics raised?
Empress Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Empress Therapeutics last raise money?
Empress Therapeutics's most recent round on record is a Series A, in Jun 2023.
What does Empress Therapeutics do?
Founded in 2020 and based in Massachusetts, US, Empress Therapeutics, Inc.
Where is Empress Therapeutics headquartered?
Empress Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Empress Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Empress Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Empress Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.